IOP Inc. Launches Osmed™ Hydrogel Tissue Expander Technology for the Treatment of Congenital Microphthalmos/Anophthalmos

Print This Post

IOP Inc. Launches Osmed™ Hydrogel Tissue Expander Technology for the Treatment of Congenital Microphthalmos/Anophthalmos

COSTA MESA, California – March 15, 2002 – IOP Inc., the premier developer and distributor of specialty devices for surgery, has launched yet another unique oculoplastic surgical technology. The Osmed™ Hydrogel Expander technology, a new advancement in tissue expansion, will be used by oculoplastic surgeons for the treatment of Congenital Microphthalmos/Anophthalmos.

osmed hydrogel IOP Inc. Launches Osmed™ Hydrogel Tissue Expander Technology for the Treatment of Congenital Microphthalmos/Anophthalmos

The Osmed™ has a distinctive advantage over the application of incremental sized conformers. The expanding hydrogel is capable of achieving expansion within weeks rather than months, giving the ocularist the ability to fit a cosmetic prosthesis much earlier. This new therapy has been described by clinicians as “one of the most promising innovations in tissue expansion.”

“We are pleased to introduce this new innovation for Anophthalmos and Microphthalmos cases.” said Jason Malecka, President of IOP Inc. “This technology provides doctors with another option to make an impact on these rare and complicated cases.”

The Osmed™ Hydrogel Tissue Expander is available as a sphere in three sizes – 2.0 ml, 3.0 ml and 4.0 ml.

IOP Ophthalmics is committed to improving the quality of life of people worldwide<85>.to elevating surgical performance through ideas, innovation and technology.

Media Contact: media@iopinc.com

This entry was posted in News. Bookmark the permalink.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>